As before, Hcy is converted to Met by methionine synthase (MetH) to complete the cycle (Figure 2) (Owens et al., 2015
Monti JM, Debellis J, Alterwain P, Pellejero T, Monti D
However, some agents [including glucagon-like peptide (GLP)-1 receptor agonists and SGLT2 inhibitors] have already demonstrated benefits in populations without diabetes, and it is these agents, along with metformin, that hold out the most promise for further investigation in sarcopenia
7.1 Ngi b suy gim chc nng thn nng Cc trng hp ny cn tuyt i tun th ch nh ca bc s chuyn khoa, khng t b sung liu cao
The EMA directed Novo Nordisk to update product labels to indicate NAION as a rare side effect, defined as occurring in up to 1 in 10,000 users after at least one year of treatment
Mol Med Rep (2018) 17(1):19937